Israel Innovation Authority
5
1
1
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Feasibility of Web-based Therapy Sessions
Role: collaborator
Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence
Role: collaborator
A Proof of Concept (PoC), Randomized, Controlled Study to Validate the Algorithm and Evaluate the Accuracy, Safety and Pain Level of the Smartest-AE in Comparison to Self-measure Blood Glucose Levels
Role: collaborator
Validation of the Dayzz Digital Sleep Training App in Insomnia and Sleep Apnea
Role: collaborator
Evaluating Astaxanthin Bioavailability, and a New Technology for Improving it, Using Natural Food Materials Only
Role: collaborator
All 5 trials loaded